|
| Status |
Public on Feb 04, 2020 |
| Title |
Comparison of Prox1 expressing and Prox1 knockout intestinal tumors and the effect of A2V+CD40 |
| Organism |
Mus musculus |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
Control or A2V+CD40 treated Prox1-proficient (AP) and Prox1-deficient (APP) tumors
|
| |
|
| Overall design |
Tumors induced in Apcflox/flox;Tp53flox/flox;villin-CreERT2 (AP) or Apcflox/flox;Tp53flox/flox;Prox1flox/flox;villin-CreERT2 (APP) mice for two weeks. Mice were randomized and treated with PBS, control IgG, or A2V+CD40 for two weeks.
|
| |
|
| Contributor(s) |
Ragusa S, Nassiri S, Petrova TV |
| Citation(s) |
32015230 |
| |
| Submission date |
Jan 06, 2019 |
| Last update date |
May 07, 2020 |
| Contact name |
Tatiana Petrova |
| E-mail(s) |
tatiana.petrova@unil.ch
|
| Organization name |
University of Lausanne
|
| Department |
Oncology
|
| Lab |
Vascular and Tumor Biology Lab
|
| Street address |
155, Chemin des Boveresses
|
| City |
Epalinges |
| State/province |
VD |
| ZIP/Postal code |
1066 |
| Country |
Switzerland |
| |
|
| Platforms (1) |
| GPL17021 |
Illumina HiSeq 2500 (Mus musculus) |
|
| Samples (19)
|
|
| Relations |
| BioProject |
PRJNA513202 |
| SRA |
SRP176286 |
Less...
More...